DocGo (DCGO) Scheduled to Post Quarterly Earnings on Wednesday

DocGo (NASDAQ:DCGO) is scheduled to be releasing its earnings data after the market closes on Wednesday, May 8th. Analysts expect DocGo to post earnings of $0.09 per share for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link.

DocGo (NASDAQ:DCGO) last announced its earnings results on Wednesday, February 28th. The company reported $0.06 EPS for the quarter, missing the consensus estimate of $0.13 by ($0.07). The company had revenue of $199.25 million for the quarter, compared to the consensus estimate of $195.48 million. DocGo had a return on equity of 2.01% and a net margin of 1.10%. On average, analysts expect DocGo to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

DocGo Stock Up 2.5 %

DocGo stock opened at $3.70 on Tuesday. The company’s 50-day moving average price is $3.72 and its two-hundred day moving average price is $4.44. The stock has a market cap of $385.43 million, a P/E ratio of 52.86, a P/E/G ratio of 0.41 and a beta of 0.96. DocGo has a twelve month low of $2.78 and a twelve month high of $10.82.

Insider Transactions at DocGo

In other DocGo news, Director Michael J. Burdiek bought 10,000 shares of the business’s stock in a transaction that occurred on Thursday, March 14th. The shares were acquired at an average cost of $3.61 per share, for a total transaction of $36,100.00. Following the transaction, the director now directly owns 571,595 shares in the company, valued at $2,063,457.95. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 13.78% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on DCGO shares. Cantor Fitzgerald dropped their price target on DocGo from $13.00 to $11.00 and set an “overweight” rating for the company in a report on Thursday, February 29th. BTIG Research reduced their target price on shares of DocGo from $13.00 to $11.00 and set a “buy” rating for the company in a research report on Wednesday, April 10th. Stifel Nicolaus lowered their price target on shares of DocGo from $8.00 to $6.50 and set a “buy” rating on the stock in a research report on Tuesday, April 30th. Canaccord Genuity Group cut their price objective on shares of DocGo from $10.00 to $9.00 and set a “buy” rating for the company in a report on Thursday, April 11th. Finally, Needham & Company LLC lowered their target price on shares of DocGo from $14.00 to $10.00 and set a “buy” rating on the stock in a report on Thursday, February 29th. Five investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, DocGo presently has a consensus rating of “Buy” and a consensus price target of $10.58.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.